Press release
Multiplex Detection Immunoassay Market Estimated to Flourish by 2024
Manufacturers in the global multiplex detection immunoassay market are focusing on introducing differential products with enhanced safety and application to increase market share. This market is significantly determined by the rising aging population, high pervasiveness of illnesses, rising utilization and enhanced focus on diagnostic testing and expanding the use of multiplex detection assay test procedures in clinical diagnostics. Moreover, concern in getting federal or government approvals due to changes in medical procedures coupled with manufacturing processes, fluctuation in result outcomes, and deficient reimbursements for multiplex detection immunoassays are representing a few difficulties to the general growth of the market during the forecast period.The capacity of multiplex detection immunoassays is to produce reportable outcomes from one example prompts to its more prominent reception for clinical or purpose of care diagnostics. Multiplex immunoassays yield an abundance of data on the parts of various proteins and different biomolecules in assorted natural procedures, in this way giving clinician’s knowledge into the distinguishing proof and evaluation of disease progression. The aim for manufacturers is to create assay kits with market driving technologies, problematic levels of multiplexing and popularize these through bigger business partners.
Multiplex stages can offer distinct advantages over singleplex measures. The requirement for lower test input has been suggested as of now; commonly 25–50 µL test volume is required to test different markers as compared with 100 µL per target required for ELISA. Moreover, multiplex stages frequently give a pickup in examining dynamic range. While ELISA quickly loses linearity over a couple orders of magnitude, multiplex assays are accounted for to keep up linearity more than three or even five orders of magnitude.
According to the latest market report published by Persistence Market Research titled ‘Global Market Study on Multiplex Detection Immunoassay: North America to Dominate the Global Market Through 2024 ’, the global multiplex detection immunoassay market is expected to witness a CAGR of 7.5% during the forecast period 2016–2024.
The global multiplex detection immunoassay market is segmented into technique, assay type, end users, and application. The planar assays segment is expected to exhibit the highest growth over the forecast period. Currently, in the U.S. market, planar assays are the mostly used for detection followed by the European market. The planar assay segment is expected to be the most lucrative in the North America multiplex detection immunoassay market, exhibiting a CAGR of 7.8%.
Based on technique, the market has been segmented into nucleic acid-based techniques, protein-based techniques and biomarker-based techniques. Protein-based techniques currently account for the highest revenue share in the market followed by nucleic acid-based techniques. Increasing focus on disease predisposition studies and drug efficacy studies would create a good opportunity for growth of multiplex detection immunoassay market.
View and Download TOC of Multiplex Detection Immunoassay Market Research Report@ https://www.persistencemarketresearch.com/market-research/multiplex-detection-immunoassay-market/toc
Based on application, the market has been segmented into disease testing (infectious disease, autoimmune disease, and others), food contamination testing, drug development and veterinary disease testing. Drug development currently accounts for the highest revenue share in the market followed by disease testing. Increasing focus on disease predisposition studies and drug efficacy studies would create a good opportunity for growth of multiplex detection immunoassay market.
Based on end users, the market has been segmented into pharmaceutical companies, clinical research organizations, food & beverages companies, academic research institutes, diagnostic centers and biotechnology companies. Currently pharmaceutical companies account for the highest revenue share in the market followed by other end users. An increasing number of multiplex assays labeled for research use only increase the growth prospects for academic research institute end users in North America during the forecast period.
Request and Download Sample Report@ https://www.persistencemarketresearch.com/samples/11542
On the basis of region, the market has been segmented into North America, Latin America, Europe, Asia-Pacific, and the MEA. This report assesses trends driving each market segment and offers analysis and insights into the potential of multiplex detection immunoassay in specific regions. North America is estimated to dominate the multiplex detection immunoassay market with a maximum value share of the overall market by end of 2016. North America multiplex detection immunoassay market is set to register a CAGR of 8.2% through 2024. The presence of key regional players, strong distribution network, and developed healthcare infrastructure are the key factors driving the growth of the market in North America.
Some key companies covered in this report include QIAGEN N.V, F. Hoffmann-La Roche AG, EMD Millipore, Bio-Rad, Microsynh AG., Thermo Fisher Scientific Inc., BD biosciences, Luminex Corporation, Unisensor, Quansys Bioscience, and Danaher Corporation. These companies are primarily focused on enhancing their market share by entering new markets and by introducing innovative and cost-effective immunoassays in order to gain higher market share and to strengthen their respective position in the global market.
Buy Full Multiplex Detection Immunoassay Market Report@ https://www.persistencemarketresearch.com/checkout/11542
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiplex Detection Immunoassay Market Estimated to Flourish by 2024 here
News-ID: 786761 • Views: …
More Releases from Persistence Market Research PVT. LTD.

Battery Material Market is projected to reach a valuation of US$ 110.02 billion …
The battery material market has witnessed significant growth in recent years, driven by the increasing demand for batteries in various applications. According to recent studies, the market was valued at USD 42.1 billion in 2022 and is projected to reach USD 110.02 billion by 2027, growing at a CAGR of 14.1% during the forecast period.
Click Here to Get Free Sample Copy of this Report@https://www.persistencemarketresearch.com/samples/10801
The battery material market encompasses a wide…

Automated Intralogistics Material Handling Solutions Market to Hit US$ 219.3 b …
Automated intralogistics material handling solution sales are anticipated to achieve a global market value of US$ 55.9 billion in 2023 and to grow steadily at a CAGR of 14.8% to reach US$ 219.3 billion by 2033.
The global intralogistics material handling solutions market is experiencing a revolution with the introduction of automated systems. Automation has become a game-changer, offering greater efficiency and productivity to businesses across the globe. The market for automated intralogistics material handling solutions is projected to witness impressive growth in the coming years.
Click Here to Get Free Sample Copy of this Report@https://www.persistencemarketresearch.com/samples/32829
The key drivers for the growth of the automated intralogistics material handling…

Cold Chain Market is Encouraged to Reach USD 474.29 billion by 2028
The global cold chain market size was valued at USD 211.77 billion in 2020 and is expected to reach USD 474.29 billion by 2028, growing at a CAGR of 9.7% from 2021 to 2028. The growth is driven by increasing demand for perishable goods, globalization of the food trade, and technological advancements in cold chain logistics.
Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3177
The cold chain market refers…

Automated Intralogistics Material Handling Solutions Market Value to Hit US$ 219 …
𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐈𝐧𝐭𝐫𝐚𝐥𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥 𝐇𝐚𝐧𝐝𝐥𝐢𝐧𝐠 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
𝐈𝐧 𝟐𝟎𝟐𝟑, 𝐬𝐚𝐥𝐞𝐬 𝐨𝐟 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐢𝐧𝐭𝐫𝐚𝐥𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐦𝐚𝐭𝐞𝐫𝐢𝐚𝐥 𝐡𝐚𝐧𝐝𝐥𝐢𝐧𝐠 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒$ 𝟓𝟓.𝟗 𝐁𝐧 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐞𝐱𝐩𝐚𝐧𝐝 𝐬𝐭𝐞𝐚𝐝𝐢𝐥𝐲 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟒.𝟖% 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐚 𝐦𝐚𝐫𝐤𝐞𝐭 𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐜𝐥𝐨𝐬𝐞 𝐭𝐨 𝐔𝐒$ 𝟐𝟏𝟗.𝟑 𝐁𝐧 𝐛𝐲 𝟐𝟎𝟑𝟑.
The demand in Germany is expected to increase by 15.7% CAGR from 2024 to 2033 on a value basis. U.S., China, and Germany are the leading countries in the…
More Releases for Multiplex
Preference of Multiplex Assays over Conventional Assays Boosts Global Multiplex …
According to a new market research report launched by Inkwood Research, the Global Multiplex Assay Market is estimated to reach around $7922.13 million by 2028, progressing with a CAGR of 8.74% over the forecasting years.
Browse 61 market data Tables and 51 Figures spread over 230 Pages, along with in-depth analysis on Global Multiplex Assay Market by Type, End-User, Product, Technology, Application & by Geography.
This insightful market research report by Inkwood…
Multiplex Assays Market Future Adoption Overview 2028
Multiplex Assays Market: Snapshot
The global multiplex assays market has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about the…
Multiplex Assays Market Segmented into types, Applications 2025
Multiplex Assays Market: Snapshot
The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about…
Multiplex Assays Market Malleable Strategies in 2025
Multiplex Assays Market: Snapshot
The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about…
Multiplex Assays Market Prominent Growth Rate by 2025
Multiplex Assays Market: Snapshot
The global market for multiplex assays has been displaying an upward movement in its valuation over the last few years. The significant surge in the need for efficient analytical platforms in R&D to reduce the operational cost is boosting the demand for multiple assays across the world. Apart from this, the rising uptake of companion diagnostics to increase the efficacy of therapies and the growing awareness about…
Multiplex Biomarker Imaging Market Outlook Report 2027
The global multiplex biomarker imaging market is estimated to be valued at US$ 270 Mn in the year 2017 and is estimated to touch a value of US$ 843 Mn in the year 2027, exhibiting a CAGR of 12% during the period of assessment (2017-2027).
Request for TOC @
https://www.futuremarketinsights.com/reports/multiplex-biomarker-imaging-market/toc
Increased spending on cancer diagnostic and monitoring
Growing incidence of cancer is resulting in increased spending by governments in various countries globally. Complications arising…